<DOC>
	<DOCNO>NCT02944968</DOCNO>
	<brief_summary>The QDOT-Micro study prospective , multi-center , non-randomized , interventional clinical study .</brief_summary>
	<brief_title>Clinical Study Workflow Performance Evaluation THERMOCOOL SMARTTOUCH速 SF-5D System Treating Symptomatic Paroxysmal AF ( QDOT-Micro )</brief_title>
	<detailed_description>The purpose study evaluate workflow acute performance , standard electrophysiology map RF ablation procedure , THERMOCOOL SMARTTOUCH速 SF-5D catheter temperature sense capability micro electrode use combination CARTO速 3 Navigation System THERMOCOOL SMARTTOUCH速 SF-5D-module .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Candidates study must meet ALL follow criterion : 1 . Age 18 old 2 . Patients sign Patient Informed Consent Form ( ICF ) 3 . Subjects drugrefractory ( fail least one Class I III antiarrhythmic drug ) symptomatic document PAF candidate catheter ablation 4 . Able willing comply pre , post , followup testing requirement ( eg . Patient confine court ruling ) Eligibility Minimum Age : 18 Years Maximum Age : Gender : Both Accepts Healthy Volunteers ? : No Criteria : Candidates study must meet ALL follow criterion : 1 . Age 18 old 2 . Patients sign Patient Informed Consent Form ( ICF ) 3 . Subjects drugrefractory ( fail least one Class I III antiarrhythmic drug ) symptomatic document PAF candidate catheter ablation 4 . Able willing comply pre , post , followup testing requirement ( eg . Patient confine court ruling ) Candidates study EXCLUDED study ANY follow condition apply : 1 . Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause . 2 . Previous ablation atrial fibrillation . 3 . Previously diagnose persistent AF . 4 . Documented Left Atrial thrombus 5 . Any carotid stenting endarterectomy 6 . LA size &gt; 50mm 7 . LVEF &lt; 40 % 8 . Uncontrolled heart failure NYHA function class III IV 9 . History blood clot bleed abnormality contraindication anticoagulation ( heparin , warfarin , dabigatran ) 10 . History document thromboembolic event ( include TIA ) within past 12 month . 11 . Previous PCI/MI within past 3 month 12 . Previous cardiac surgery ( e.g CABG ) valvular cardiac surgical/percutaneous procedure ( e.g ventriculotomy , atriomy , valve repair replacement , presence prosthetic valve ) . 13 . Awaiting cardiac transplantation cardiac surgery within next 6 month . 14 . Unstable angina 15 . Significant pulmonary disease ( eg , restrictive pulmonary disease , constrictive chronic obstructive pulmonary disease ) disease malfunction lungs respiratory system produce chronic symptom . 16 . Acute illness , active systemic infection , sepsis . 17 . Presence intracardiac thrombus , myxoma , tumor , interatrial baffle patch abnormality precludes catheter introduction manipulation . 18 . Presence condition precludes vascular access . 19 . Presence implantable cardioverterdefibrillator ( ICD ) 20 . Significant congenital anomaly medical problem opinion investigator would preclude enrollment trial . 21 . Currently enrol investigational study evaluate another device , biologics , drug . 22 . Women child bear potential pregnant , lactate , plan become pregnant course clinical investigation ( evidenced pregnancy test child bear potential ) . 23 . Life expectancy le 12 month . 24 . Presenting contraindication device use study , indicate respective instruction use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Interventional</keyword>
	<keyword>Radiofrequency Ablation</keyword>
	<keyword>Paroxysmal Atrial Fibrillation</keyword>
</DOC>